- 如果您對該產(chǎn)品感興趣的話，可以
- 產(chǎn)品名稱：Anti-SPATA9抗體
- 產(chǎn)品型號：精子發(fā)生相關蛋白9抗體
- 產(chǎn)品展商：KALANG
- 產(chǎn)品文檔：無相關文檔
- 發(fā)布時間：2018-07-30
- 在線詢價
簡單介紹
Anti-SPATA9抗體產(chǎn)品質(zhì)量穩(wěn)定，實驗效果明顯，貨期快，價格優(yōu)惠，歡迎垂詢訂購！我公司長期供應**組化抗體、WB抗體、**組化試劑盒和抗體試驗所需全部相關試劑、熒光標記抗體、單克隆抗體、多克隆抗體、各種標記的二抗IgG/IgM/IgD/IgA等科研實驗抗體。Anti-SPATA9抗體用于**組化實驗,WB實驗,相應的標記抗體有HRP標記抗體,FITC標記,BIO等。
產(chǎn)品描述
Rabbit Anti-SPATA9
Cat. Number:
Anti-SPATA9抗體KL-17635R
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
SPATA9 is a 254 amino acid single-pass membrane protein that is highly expressed in testis and pancreas with low expression in heart, lung, and brain. A component of the sperm acrosome, SPATA9 may participate in sperm capacitation and acrosome reaction, and is therefore necessary for fertilization. SPATA9 is Anti-SPATA9抗體also suggested to be involved in testicular development/spermatogenesis and may be an important factor in male infertility. No expression of SPATA9 was found in patients affected by Sertoli-cell-only syndrome, also known as Del Castillo syndrome or germ cell aplasia, which is characterized by male sterility without sexual abnormality. SPATA9 is encoded by a gene located on human chromosome 5, which consists of about 181 million base pairs, encodes around 1,000 genes and represents about 6% of human genomic DNA.
Also known as:
FLJ35906; NYD SP16; Anti-SPATA9抗體spermatogenesis associated 9; Spermatogenesis associated protein 9; Testis development protein NYD SP16.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, Pig, Cow, Sheep, .
●
Immunogen: KLH conjugated Anti-SPATA9抗體synthetic peptide derived from human SPATA9.
●
Predicted Molecular Weight: 29kDa.
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500 Anti-SPATA9抗體
Not yet tested in other applications.
Optimal working dilutions must be determined by the end user.
